- Home
- GNRC vs BRKR Comparison
GNRC vs BRKR Comparison
Compare GNRC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNRC
- BRKR
- Stock Information
- Founded
- GNRC 1959
- BRKR 1960
- Country
- GNRC United States
- BRKR United States
- Employees
- GNRC 9239
- BRKR N/A
- Industry
- GNRC Metal Fabrications
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- GNRC Consumer Discretionary
- BRKR Industrials
- Exchange
- GNRC Nasdaq
- BRKR Nasdaq
- Market Cap
- GNRC 11.3B
- BRKR 5.3B
- IPO Year
- GNRC 2010
- BRKR 2000
- Fundamental
- Price
- GNRC $193.08
- BRKR $38.72
- Analyst Decision
- GNRC Buy
- BRKR Buy
- Analyst Count
- GNRC 19
- BRKR 10
- Target Price
- GNRC $188.74
- BRKR $49.67
- AVG Volume (30 Days)
- GNRC 944.8K
- BRKR 3.4M
- Earning Date
- GNRC 10-29-2025
- BRKR 11-03-2025
- Dividend Yield
- GNRC N/A
- BRKR 0.51%
- EPS Growth
- GNRC 54.62
- BRKR N/A
- EPS
- GNRC 6.03
- BRKR 0.52
- Revenue
- GNRC $4,411,654,000.00
- BRKR $3,442,800,000.00
- Revenue This Year
- GNRC $5.13
- BRKR $4.30
- Revenue Next Year
- GNRC $8.48
- BRKR $1.51
- P/E Ratio
- GNRC $31.82
- BRKR $74.89
- Revenue Growth
- GNRC 9.69
- BRKR 10.36
- 52 Week Low
- GNRC $99.50
- BRKR $28.53
- 52 Week High
- GNRC $203.25
- BRKR $64.64
- Technical
- Relative Strength Index (RSI)
- GNRC 61.26
- BRKR 61.19
- Support Level
- GNRC $180.32
- BRKR $38.60
- Resistance Level
- GNRC $195.20
- BRKR $41.08
- Average True Range (ATR)
- GNRC 6.84
- BRKR 1.64
- MACD
- GNRC 1.63
- BRKR 0.25
- Stochastic Oscillator
- GNRC 87.39
- BRKR 66.12
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.